Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B H Arison

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 9, 1997
In vitro metabolism of simvastatin in humans [SBT]identification of metabolizing enzymes and effect of the drug on hepatic P450sT Prueksaritanont, L M Gorham, B Ma, et al.
The Journal of Biological Chemistry|April 4, 1997
Farnesol-derived dicarboxylic acids in the urine of animals treated with zaragozic acid A or with farnesolR G Bostedor, J D Karkas, B H Arison, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 1, 1995
Metabolites of L-735,524, a potent HIV-1 protease inhibitor, in human urineS K Balani, B H Arison, L Mathai, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1986
Metabolic disposition of ivermectin in tissues of cattle, sheep, and ratsS H Chiu, E Sestokas, R Taub, et al.
The Journal of Antibiotics|February 1, 1986
Biosynthesis of fluorothreonine and fluoroacetic acid by the thienamycin producer, Streptomyces cattleyaM Sanada, T Miyano, S Iwadare, et al.
Chemico-Biological Interactions|April 1, 1984
Drug residue formation from ronidazole, a 5-nitroimidazole. V. Cysteine adducts formed upon reduction of ronidazole by dithionite or rat liver enzymes in the presence of cysteineP G Wislocki, E S Bagan, W J Vandenheuvel, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1973
Physiologic disposition and metabolic fate of a new anti-inflammatory agent, cis-5-fluro-2-methyl-1-(p-(methylsulfinyl)-benzylidenyl)-indene-3-acetic acid in the rat, dog, rhesus monkey, and manH B Hucker, S C Stauffer, S D White, et al.
Journal of Pharmaceutical Sciences|September 1, 1979
Urinary metabolites of 3a,4,5,6,7,7a-hexahydro-3-(1-methyl-5-nitro-1H-imidazol-2-yl)-1,2-benzisoxazole in the dogW J Vandenheuvel, B H Arison, T W Miller, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 1, 1991
Metabolism of the platelet-activating factor antagonist (+/-)-trans-2-(3'-methoxy-5'-methylsulphonyl-4'-propoxyphenyl)-5-(3",4" ,5"- trimethoxyphenyl)tetrahydrofuran (L-659,989) in rhesus monkeysK L Thomson, M N Chang, R L Bugianesi, et al.
Biochemical and Biophysical Research Communications|December 31, 1991
HIV-1 protease inhibitory activity of L-694,746, a novel metabolite of L-689,502R B Lingham, B H Arison, L F Colwell, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 9, 1997
In vitro metabolism of simvastatin in humans [SBT]identification of metabolizing enzymes and effect of the drug on hepatic P450sT Prueksaritanont, L M Gorham, B Ma, et al.
The Journal of Biological Chemistry|April 4, 1997
Farnesol-derived dicarboxylic acids in the urine of animals treated with zaragozic acid A or with farnesolR G Bostedor, J D Karkas, B H Arison, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 1, 1995
Metabolites of L-735,524, a potent HIV-1 protease inhibitor, in human urineS K Balani, B H Arison, L Mathai, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1986
Metabolic disposition of ivermectin in tissues of cattle, sheep, and ratsS H Chiu, E Sestokas, R Taub, et al.
The Journal of Antibiotics|February 1, 1986
Biosynthesis of fluorothreonine and fluoroacetic acid by the thienamycin producer, Streptomyces cattleyaM Sanada, T Miyano, S Iwadare, et al.
Chemico-Biological Interactions|April 1, 1984
Drug residue formation from ronidazole, a 5-nitroimidazole. V. Cysteine adducts formed upon reduction of ronidazole by dithionite or rat liver enzymes in the presence of cysteineP G Wislocki, E S Bagan, W J Vandenheuvel, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1973
Physiologic disposition and metabolic fate of a new anti-inflammatory agent, cis-5-fluro-2-methyl-1-(p-(methylsulfinyl)-benzylidenyl)-indene-3-acetic acid in the rat, dog, rhesus monkey, and manH B Hucker, S C Stauffer, S D White, et al.
Journal of Pharmaceutical Sciences|September 1, 1979
Urinary metabolites of 3a,4,5,6,7,7a-hexahydro-3-(1-methyl-5-nitro-1H-imidazol-2-yl)-1,2-benzisoxazole in the dogW J Vandenheuvel, B H Arison, T W Miller, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 1, 1991
Metabolism of the platelet-activating factor antagonist (+/-)-trans-2-(3'-methoxy-5'-methylsulphonyl-4'-propoxyphenyl)-5-(3",4" ,5"- trimethoxyphenyl)tetrahydrofuran (L-659,989) in rhesus monkeysK L Thomson, M N Chang, R L Bugianesi, et al.
Biochemical and Biophysical Research Communications|December 31, 1991
HIV-1 protease inhibitory activity of L-694,746, a novel metabolite of L-689,502R B Lingham, B H Arison, L F Colwell, et al.
Pageof 9